Clinical studies show that focal treatment is a recommended approach for the recovery of some cancers, ensuring functional preservation of affected organs. Today, these treatments are quite well standardized for surgery:
- lumpectomy for kidney cancer;
- metastasectomy for liver and lung;
- pulmonary lobectomy...
Unfortunately, tumors are frequently smaller than half an inch in size, which makes them challenging to pinpoint accurately, especially considering their increased mobility during the treatment process due to variations in organ positioning, breathing-related movements, and the surrounding environment. For percutaneous physical treatments like cryotherapy or thermotherapy, the exact location of the treatment probe on the tumor is either done manually or relies on radiological or ultrasound imaging. In this case, the success of focal treatment is directly tied to the accuracy of the imaging, as errors in probe placement can directly affect the procedure's success rate.
BronchoscopyΒΆ
Cobodoc system enhances the accuracy of cancer cell treatment procedures, restricts the treatment diameter, and simplifies the use of focal treatments designed to eliminate the target while preserving the organ. With the Cobodoc system, the medical team achieves better and more reproducible results when destroying tumors in several organs including: pleura and lung, breast, liver, kidney, prostate, endometrium, cervix and ovaries, pancreas, and adrenals.
The Cobodoc system is designed for surgeries like thoracic surgery to treat lung cancer with a wider field of treatment. Thanks to the ergonomics and flexibility of the cobot's arms, the Cobodoc system offers the distinct advantage of avoiding the need to open the patient's ribcage. Instead, it simply creates a few small incisions between the ribs to accommodate the arms equipped with instruments and cameras.